Indications
Pergoveris is indicated for the stimulation of follicular development in women with severe luteinising-hormone (LH) and follicle-stimulating-hormone deficiency. In clinical trials, these patients were defined by an endogenous serum LH level <
1.2 IU/l.
Composition
- Active substance
- follitropin alfa, lutropin alfa
- International name (INN)
- follitropin alfa;lutropin alfa
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Pergoveris
- Active substance
- follitropin alfa, lutropin alfa
- ATC code
- G03GA30